4//SEC Filing
Oxtoby Andrew 4
Accession 0000950170-25-053347
CIK 0001754068other
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 4:55 PM ET
Size
5.6 KB
Accession
0000950170-25-053347
Insider Transaction Report
Form 4
Oxtoby Andrew
DirectorSee Remarks
Transactions
- Award
Stock Option (Right to Buy)
2025-04-10+287,000→ 287,000 totalExercise: $7.31Exp: 2035-04-09→ Common Stock (287,000 underlying)
Footnotes (1)
- [F1]The option was granted on April 10, 2025. The shares underlying the option are scheduled to vest over four years, with 25% of the shares underlying the option vesting on March 18, 2026, and the remainder vesting in equal monthly installments thereafter, subject to continuous service.
Documents
Issuer
Kalaris Therapeutics, Inc.
CIK 0001754068
Entity typeother
Related Parties
1- filerCIK 0001765473
Filing Metadata
- Form type
- 4
- Filed
- Apr 10, 8:00 PM ET
- Accepted
- Apr 11, 4:55 PM ET
- Size
- 5.6 KB